Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06246409 · ClinicalTrials.gov registry record · NA

Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy

A NA study of Cancer, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
650
Enrollment target
1
Study location

NCT06246409 is a NA study of Cancer that is actively recruiting participants, run by University of Florida. The registered enrollment target is 650 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06246409, a NA study of Cancer, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
650 participants
Enrollment target
1
Study location

Study Summary

Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction materials and measure whether the improvement in clarity and specificity produces the desired changes in patient decision-making and emotional comfort.

Conditions Studied

Interventions

  • BEHAVIORAL Modernized patient instructions
  • BEHAVIORAL Existing patient instructions

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2024-12-24
Est. Completion 2026-12
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT06246409

The ClinicalTrials.gov registry entry for NCT06246409 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (81% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Modernized patient instructions is the first listed.

NCT06246409 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06246409 about?

NCT06246409 is a clinical study titled "Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy". Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction material...

What is the current status of trial NCT06246409?

This trial is currently recruiting. It is a NA study. The enrollment target is 650 participants. The study started on 2024-12-24. Estimated completion is 2026-12.

What conditions does trial NCT06246409 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06246409?

The interventions under investigation include: Modernized patient instructions (BEHAVIORAL), Existing patient instructions (BEHAVIORAL).

Who is sponsoring clinical trial NCT06246409?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06246409 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.